Daewon Pharmaceutical Co., Ltd. (KRX: 003220)
South Korea
· Delayed Price · Currency is KRW 14,180
+180 (1.29%)
Nov 15, 2024, 3:30 PM KST
Daewon Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 305,427 | 331,930 | 393,197 | 342,999 | 380,715 | 335,002 | Upgrade
|
| Market Cap Growth | 0.08% | -15.58% | 14.64% | -9.91% | 13.65% | 10.32% | Upgrade
|
| Enterprise Value | 445,384 | 418,509 | 453,068 | 412,231 | 412,859 | 369,245 | Upgrade
|
| Last Close Price | 14250.00 | 15660.00 | 18388.50 | 15555.07 | 17051.94 | 14640.82 | Upgrade
|
| PE Ratio | 21.02 | 14.10 | 12.44 | 47.23 | 20.63 | 11.57 | Upgrade
|
| Forward PE | 7.67 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 | Upgrade
|
| PS Ratio | 0.53 | 0.63 | 0.82 | 0.97 | 1.23 | 1.05 | Upgrade
|
| PB Ratio | 1.13 | 1.26 | 1.58 | 1.57 | 1.79 | 1.64 | Upgrade
|
| P/TBV Ratio | 1.35 | 1.37 | 1.74 | 1.77 | 1.88 | 1.73 | Upgrade
|
| P/FCF Ratio | - | 8.41 | 21.36 | 18.73 | 27.98 | - | Upgrade
|
| P/OCF Ratio | 92.41 | 6.42 | 14.89 | 15.30 | 15.26 | 10.82 | Upgrade
|
| PEG Ratio | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | Upgrade
|
| EV/Sales Ratio | 0.79 | 0.79 | 0.95 | 1.16 | 1.34 | 1.16 | Upgrade
|
| EV/EBITDA Ratio | 9.88 | 8.40 | 7.28 | 11.11 | 10.41 | 7.89 | Upgrade
|
| EV/EBIT Ratio | 16.63 | 12.98 | 10.56 | 21.36 | 17.22 | 10.56 | Upgrade
|
| EV/FCF Ratio | -27.29 | 10.61 | 24.62 | 22.51 | 30.35 | - | Upgrade
|
| Debt / Equity Ratio | 0.68 | 0.55 | 0.47 | 0.57 | 0.25 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 4.27 | 2.93 | 1.87 | 3.34 | 1.32 | 1.09 | Upgrade
|
| Debt / FCF Ratio | - | 3.70 | 6.33 | 6.77 | 3.86 | - | Upgrade
|
| Asset Turnover | 1.09 | 1.10 | 1.08 | 0.93 | 0.93 | 1.05 | Upgrade
|
| Inventory Turnover | 2.77 | 2.76 | 3.01 | 2.69 | 2.49 | 2.89 | Upgrade
|
| Quick Ratio | 0.63 | 0.56 | 0.89 | 1.07 | 0.93 | 1.08 | Upgrade
|
| Current Ratio | 1.19 | 1.15 | 1.62 | 1.77 | 2.09 | 1.97 | Upgrade
|
| Return on Equity (ROE) | 4.70% | 9.15% | 13.12% | 3.07% | 8.25% | 13.88% | Upgrade
|
| Return on Assets (ROA) | 3.18% | 4.19% | 6.07% | 3.15% | 4.52% | 7.25% | Upgrade
|
| Return on Capital (ROIC) | 3.92% | 5.20% | 7.58% | 3.97% | 5.76% | 9.37% | Upgrade
|
| Earnings Yield | 4.76% | 7.21% | 8.12% | 2.04% | 4.63% | 8.15% | Upgrade
|
| FCF Yield | -5.34% | 11.88% | 4.68% | 5.34% | 3.57% | -0.61% | Upgrade
|
| Dividend Yield | 2.12% | 1.92% | - | 1.25% | 0.91% | 1.59% | Upgrade
|
| Payout Ratio | 43.29% | 30.69% | 12.90% | 44.93% | 28.54% | 17.91% | Upgrade
|
| Buyback Yield / Dilution | 0.16% | 0.98% | -3.09% | 0.58% | 1.06% | 0.01% | Upgrade
|
| Total Shareholder Return | 2.28% | 2.90% | -3.09% | 1.83% | 1.97% | 1.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.